Effect of minoxidil formulations on human scalp skin xenotransplants on SCID mice: A novel pre-clinical in vivo assay for androgenetic alopecia research
Exp Dermatol
.
2022 Jun;31(6):980-982.
doi: 10.1111/exd.14523.
Epub 2022 Jan 21.
Authors
Amos Gilhar
1
2
,
Aviad Keren
1
2
,
Yehuda Ullmann
1
2
,
Jeff Wu
3
,
Ralf Paus
4
5
6
Affiliations
1
Skin Research Laboratory, Rappaport Faculty of Medicine, Technion -Israel Institute of Technology, Haifa, Israel.
2
Rambam Health Care Campus, Haifa, Israel.
3
Johnson & Johnson Consumer, Inc., Skillman, New Jersey, USA.
4
Dr. Philipp Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
5
Centre for Dermatology Research, University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, UK.
6
Monasterium Laboratory, Münster, Germany.
PMID:
35000229
DOI:
10.1111/exd.14523
No abstract available
Publication types
Letter
MeSH terms
Administration, Topical
Alopecia / drug therapy
Animals
Hair
Humans
Mice
Mice, SCID
Minoxidil* / pharmacology
Minoxidil* / therapeutic use
Scalp*
Treatment Outcome
Substances
Minoxidil